Delivering precision and sterility at scale

SCHOTT Poonawalla, a ₹1,000+ crore powerhouse, has emerged as a trusted partner in India's injectable packaging landscape

- 

India's pharmaceutical industry is on an upward curve, fuelled by rising demand for vaccines, biologics, and advanced therapies. As focus sharpens on the packaging that protects these critical medicines, SCHOTT Poonawalla (SPPL) emerges as a trusted partner in the country’s injectable packaging landscape.

End-to-end solutions

SPPL designs advanced drug containment and delivery solutions for pharmaceutical and biotechnology customers. The company’s portfolio features a large range of products including cartridges for auto-injector pens and pre-fillable syringes for a wide variety of biologics in addition to large quantity of vials and ampoules. The company also provides regulatory services for a diverse base of more than 200 customers including top biotech and pharmaceutical companies, and contract development and manufacturing organisations (CDMOs).